Seeing Is Believing
Currently out of the existing stock ratings of Daniel Stauder, 18 are a BUY (100%).
Analyst Daniel Stauder, currently employed at JMP, carries an average stock price target met ratio of 50% that have a potential upside of 11.16% achieved within 91 days.
Daniel Stauder’s has documented 35 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AORT, Artivion at 08-May-2026.
Analyst best performing recommendations are on AORT (ARTIVION).
The best stock recommendation documented was for AORT (ARTIVION) at 8/8/2025. The price target of $42 was fulfilled within 3 days with a profit of $1.05 (2.56%) receiving and performance score of 8.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Jun-2025
$36
$12.39 (52.48%)
$48
1 months 3 days ago
(16-Jun-2026)
1/4 (25%)
$14.55 (67.83%)
52
Buy Since 18-Feb-2022
$44
$20.39 (86.36%)
$58
2 months 11 days ago
(08-May-2026)
18/23 (78.26%)
$18.59 (73.16%)
317
Buy Since 23-Oct-2024
$48
$24.39 (103.30%)
$47
2 months 11 days ago
(08-May-2026)
5/6 (83.33%)
$22.59 (88.90%)
131
Buy Since 08-Aug-2022
$55
$31.39 (132.95%)
$32
8 months 12 days ago
(07-Nov-2025)
5/6 (83.33%)
$10.13 (22.58%)
657
Buy Since 02-Mar-2022
$46
$22.39 (94.83%)
$36
9 months 20 days ago
(29-Sep-2025)
10/10 (100%)
$3.96 (9.42%)
184
Which stock is Daniel Stauder is most bullish on?
Which stock is Daniel Stauder is most reserved on?
What Year was the first public recommendation made by Daniel Stauder?